BD names Stewart to SVP of strategy, investor relations

    BD, a global medical technology company based in Franklin Lakes, announced on Monday it has appointed Kristen Stewart to the newly-created role of senior vice president of strategy and investor relations, effective Aug. 31.

    In this role, Stewart will work with BD’s executive team to drive shareholder value and help deliver the company’s long-term growth strategy. Prior to BD, Stewart worked at Wall Street investment banks for nearly two decades. Most recently, she led the medical technology franchise at Barclays Capital.

    “As a highly respected analyst in our sector, Kristen brings a deep understanding of the medical technology industry to BD,” Tom Polen, CEO and president, BD, said. “I am confident her strong strategic and analytical skills will serve the company and our stakeholders tremendously well, and I look forward to her partnership as we continue to execute our strategy.”

    Stewart began her financial career at PricewaterhouseCoopers.

    “I have watched through the analyst lens as BD has transformed into a global medical technology innovator. I am excited by BD’s current strategic direction and believe the company has significant potential to optimize shareholder value. I am thrilled to undertake this important new role,” Stewart said.